An economic evaluation of screening for hereditary haemochromatosis in the French population;Évaluation économique du dépistage de l'hémochromatose HFE1 en France en population générale

Journal d'Economie Medicale

Volumn 23, Issue 1, 2005, Pages 15-26

  Barre S ^a   Preaubert N ^a   Delaveyne, R ^a   Cecchin, M ^a  

^a ANAES   (France)

Author keywords

Economic evaluation; Hereditary haemochromatosis; Modelling; Screening

Indexed keywords

ARTICLE; DECISION THEORY; DIAGNOSTIC ACCURACY; ECONOMIC EVALUATION; FRANCE; GENETIC DISORDER; GENETIC SCREENING; GENOTYPE; HEALTH CARE COST; HEALTH INSURANCE; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MARGINAL COST; MASS SCREENING; METHODOLOGY; MODEL; PHENOTYPE; POPULATION RESEARCH;

EID: 16844365274     PISSN: 02940736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fergelot P, Le Gall JY, Mosser J. Hémochromatoses et surcharges primitives en fer. Rev Fr Lab 2002;339:39-43.
2. Agence nationale d'accréditation et d'évaluation en santé. Évaluation clinique et économique de l'intérêt du dépistage de l'hémochromatose génétique en France. Paris: Anaes; 1999.
3. Agence nationale pour le développement de l'évaluation médicale. Évaluation de l'opportunité d'un programme national de dépistage: l'exemple de l'hémochromatose génétique. Paris: Andem; 1995.
4. Agence nationale d'accréditation et d'évaluation en santé. Évaluation clinique et économique du dépistage de l'hémochromatose HFE1 en 2004. Saint-Denis: Anaes; 2004.
5. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.
6. Institut national de la statistique et des études économiques. Recensement de la population. Mars 1999. Les résultats. http://www.recensement.insee.fr/RP99/rp99/page_accueil. paccueil [consulté le 01-03-04].
7. Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 1994;154(7):769-76.
8. Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Gastroenterology 1995; 109(1):177-88.
9. Schöffski O, Schmidtke J, Stuhrmann M. Cost-effectiveness of population-based genetic hemochromatosis screening. Community Genet 2000;3(1):2-11.
10. Bassett ML, Leggett BA, Halliday JW, Webb S, Powell LW. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. J Hepatol 1997;27 (3):517-24.
11. Adams PC, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping. Am J Gastroenterol 1999;94(6):1-9.
12. Greenwood TG, Pathak DS. A decision analysis model for screening of hereditary hemochromatosis. In International Society for Pharmacoeconomics and Outcome Research Seventh Annual International Meeting, Crystal City Arlington, 19-22 may 2002. http://www.ispor.org/meetings/ va0502/presentations/session1/ PHP45.pdf [consulté le 11-06-03].
13. Steinmetz J, Spyckerelle Y, Henny J, Giordanella JP, Emmanuelli J. Dépistage du cancer colorectal dans la population consultant un centre d'examens de santé. Bull Épidémiol Hebdo 2000;(49).
14. Ancelle-Park R, Nicolau J. Évaluation du programme de dépistage organisé du cancer du sein: résultats 1999. Bull Épidémiol Hebdo 2001;(27).
15. McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 1999;107(1):30-7.
16. Aguilar-Martinez P, Picot MC, Becker F, Boulot P, Montoya F, Mares P et al. Prevalence of HFE mutations in people from North Africa living in southern France. Br J Haematol 2001;114(4): 914-6.
17. Cadet E, Capron D, Perez AS, Crepin SN, Arlot S, Ducroix JP et al. A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis. J Intern Med 2003;253(2):217-24.
18. Jézéquel P, Bargain M, Lellouche F, Geffroy F, Dorval I. Allele frequencies of hereditary hemochromatosis gene mutations in a local population of west Brittany. Hum Genet 1998;102(3): 332-3.
19. Mura C, Raguenes O, Férec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;93(8):2502-5.
20. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJH. Geography of HFE C282Y and H63D mutations. Genet Test 2000;4(2):183-98.
21. Åsberg A, Hveem K, Thorstensen K, Ellekjaer E, Kannelønning K, Fjøsne U et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36(10): 1108-15.
22. Deugnier Y, Jouanolle AM, Chaperon J, Moirand R, Pithois C, Meyer JF et al. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 french people. Br J Haematol 2002; 118(4):1170-8.
23. Dautreaux-Lagarde M. Dépistage de l'hémochromatose génétique chez 991 assurés sociaux volontaires pour un bilan de santé [thèse]. Amiens: université de Picardie Jules-Verne; 1999.